Related Experiment Videos
Systemic inflammation in COPD: is genetic susceptibility a key factor?
Dilyara G Yanbaeva1, Mieke A Dentener, Eva C Creutzberg
1Department of Respiratory Medicine, University Hospital Maastricht, 6202 AZ Maastricht, The Netherlands. D.Yanbaeva@pul.unimaas.nl
COPD
|December 21, 2006
Summary
Chronic Obstructive Pulmonary Disease (COPD) involves systemic inflammation, potentially influenced by genetic factors. Further research is needed to understand the role of gene polymorphisms in COPD
Area of Science:
- Pulmonary Medicine
- Genetics
- Immunology
Background:
- COPD is a complex lung disease with systemic effects like weight loss and reduced functional capacity.
- A low-grade systemic inflammation, indicated by elevated C-reactive protein (CRP) and tumor necrosis factor-alpha (TNF-alpha), is observed in some COPD patients.
- Genetic factors influence the production of inflammatory proteins.
Purpose of the Study:
- To explore the role of genetic polymorphisms in the systemic inflammatory component of COPD.
- To identify specific gene polymorphisms, such as those in the TNF, IL-6, and CRP genes, that may influence COPD's systemic effects.
Main Methods:
- Review of existing studies on COPD, systemic inflammation, and genetic polymorphisms.
- Focus on polymorphisms within genes encoding inflammatory mediators like TNF-alpha, lymphotoxin-alpha (LT-alpha), their receptors (TNF-R55, TNF-R75), IL-6, and CRP.
- Emphasis on the need for large, well-designed studies in well-characterized COPD cohorts.
Main Results:
- Genetic polymorphisms in inflammatory mediator genes are potential modulators of systemic inflammation in COPD.
- TNF, IL-6, and CRP gene polymorphisms are identified as prominent candidates requiring further investigation.
- Current evidence suggests a genetic basis for the systemic inflammatory response in COPD, but definitive conclusions are pending.
Conclusions:
- Genetic background plays a role in the systemic component of COPD.
- Further large-scale, well-designed studies are essential to elucidate the precise impact of genetic polymorphisms on COPD-related systemic inflammation.
- Understanding these genetic influences could lead to more targeted therapeutic strategies for COPD.
Related Concept Videos
01:23Chronic Obstructive Pulmonary Disease I: Introduction
Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
01:20COPD: Pathogenesis and Clinical Features
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
01:24Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
01:24Chronic Obstructive Pulmonary Disease
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...